News
Reeling from an FDA rejection, Telesta sheds 15% of its staff By Damian Garde Mar 9, 2016 9:29am Biotech Telesta CEO Michael Berendt ...
Type A Meeting request submitted to US FDA Expenditure reductions implemented and ongoing Strategic review process initiated MONTREAL, March 9, 2016 /PRNewswire/ - Telesta Therapeutics Inc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback